Previous studies have demonstrated that ITGBL1 is highly expressed in some types of cancer and its overexpression promotes cancer progression in colorectal cancer (15), ovarian cancer (16), and hepatocellular carcinoma (17). Here, ITGBL1 is linked to cancer.